Tissue Regenix Group (LSE:TRX) Days Inventory : 239.69 (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Tissue Regenix Group Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Tissue Regenix Group's Average Total Inventories for the six months ended in Dec. 2023 was £8.59 Mil. Tissue Regenix Group's Cost of Goods Sold for the six months ended in Dec. 2023 was £6.54 Mil. Hence, Tissue Regenix Group's Days Inventory for the six months ended in Dec. 2023 was 239.69.

The historical rank and industry rank for Tissue Regenix Group's Days Inventory or its related term are showing as below:

LSE:TRX' s Days Inventory Range Over the Past 10 Years
Min: 115.7 Med: 255.91 Max: 376.06
Current: 259.95

During the past 13 years, Tissue Regenix Group's highest Days Inventory was 376.06. The lowest was 115.70. And the median was 255.91.

LSE:TRX's Days Inventory is ranked worse than
61.77% of 654 companies
in the Biotechnology industry
Industry Median: 189.655 vs LSE:TRX: 259.95

Tissue Regenix Group's Days Inventory declined from Dec. 2022 (279.52) to Dec. 2023 (239.69).

Inventory Turnover measures how fast the company turns over its inventory within a year. Tissue Regenix Group's Inventory Turnover for the six months ended in Dec. 2023 was 0.76.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Tissue Regenix Group's Inventory-to-Revenue for the six months ended in Dec. 2023 was 0.71.

Tissue Regenix Group Days Inventory Historical Data

The historical data trend for Tissue Regenix Group's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tissue Regenix Group Days Inventory Chart

Tissue Regenix Group Annual Data

Trend

Jan14

Jan15

Jan16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Inventory

Get a 7-Day Free Trial

169.68

312.21

311.25

273.16

255.91

Tissue Regenix Group Semi-Annual Data
	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Inventory	Get a 7-Day Free Trial															289.06	271.23	279.52	287.95	239.69

Competitive Comparison of Tissue Regenix Group's Days Inventory

For the Biotechnology subindustry, Tissue Regenix Group's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tissue Regenix Group's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tissue Regenix Group's Days Inventory distribution charts can be found below:

* The bar in red indicates where Tissue Regenix Group's Days Inventory falls into.

Tissue Regenix Group Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Tissue Regenix Group's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

	Days Inventory (A: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (8.934	+	8.183)	/	2 )	/	12.207	*	365
=	8.5585					/	12.207	*	365
=	255.91

Tissue Regenix Group's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

	Days Inventory (Q: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Jun. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (8.996	+	8.183)	/	2 )	/	6.54	*	365 / 2
=	8.5895					/	6.54	*	365 / 2
=	239.69

Tissue Regenix Group (LSE:TRX) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Tissue Regenix Group's Inventory Turnover for the six months ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	6.54	/	8.5895
	=	0.76

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Tissue Regenix Group's Inventory to Revenue for the six months ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	8.5895	/	12.162
	=	0.71

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Tissue Regenix Group Days Inventory Related Terms

Thank you for viewing the detailed overview of Tissue Regenix Group's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Tissue Regenix Group (LSE:TRX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tissue Regenix Group PLC (LSE:TRX) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

LSW:Germany

Address

Lotherton Way, Unit 3, Phoenix Court, Garforth, GBR, LS25 2GY

Website

https://www.tissueregenix.com

Tissue Regenix Group PLC is a pioneering medical technology company engaged in the development of regenerative products. The company incorporates dCELL and BioRinse technology, which helps to address complex and varying clinical needs. Its product portfolio includes Biosurgery, Orthopaedics, and Dental. The company has operations around the world, with special emphasis in the United States.